GlassScriptPhysician profile
Candice Bertsch
NPI 1841920030
$8,207.89
in general payments reported to CMS, 2019-2025
71 companies · $2,310 in 2025
The $2,310 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $742 · 2023: $2,170 · 2024: $2,986 · 2025: $2,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,432 · Education: $34.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,431.60 |
| Education | $34.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $709.21 | 2022-2025 | Monjuvi, Jakafi, Pemazyre |
| Genentech USA, INC. | $446.29 | 2023-2025 | Tecentriq, Polivy, Columvi |
| Janssen Biotech, INC. | $431.31 | 2023-2025 | Erleada, Darzalex, Tecvayli |
| Novartis Pharmaceuticals Corporation | $428.42 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $341.72 | 2022-2025 | Libtayo |
| Merck Sharp & Dohme LLC | $330.12 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $292.86 | 2022-2025 | Lynparza, Calquence, Imfinzi |
| Lilly USA, LLC | $274.03 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $261.82 | 2022-2024 | Fruzaqla, Ninlaro, Hyqvia |
| Daiichi Sankyo INC. | $251.29 | 2023-2025 | Enhertu, Datroway, Injectafer |
| Celgene Corporation | $220.86 | 2023-2025 | Reblozyl, Opdivo |
| Eagle Pharmaceuticals, INC. | $207.65 | 2024 | |
| Genzyme Corporation | $192.29 | 2022-2025 | |
| Seagen INC. | $169.28 | 2022-2023 | Adcetris, Padcev, Tukysa |
| Pfizer INC. | $159.61 | 2024-2025 |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $147.73 | 2023-2025 | Onivyde, Somatuline Depot |
| Myriad Genetic Laboratories, INC. | $141.15 | 2023 | Bracanalysis, Bracanalysis Cdx |
| Abbvie INC. | $135.66 | 2024-2025 | |
| Array Biopharma INC | $125.73 | 2024-2025 | Braftovi, Mektovi, Lorbrena |
| Bayer Healthcare Pharmaceuticals INC. | $125.45 | 2023-2025 | |
| Novo Nordisk INC | $119.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $107.90 | 2025 | Opdivo, Opdualag |
| Eisai INC. | $103.17 | 2022-2025 | |
| Pharmaessentia USA Corporation | $102.65 | 2023-2025 | Besremi |
| Aveo Pharmaceuticals, INC. | $99.58 | 2022-2025 | |
| United Therapeutics Corporation | $96.75 | 2022 | |
| Deciphera Pharmaceuticals INC. | $92.79 | 2023-2025 | Qinlock, Romvimza |
| Beigene USA, INC. | $89.00 | 2024-2025 | Brukinsa |
| Exelixis INC. | $87.96 | 2022-2025 | Cabometyx |
| Genmab U.S., INC. | $82.54 | 2023-2025 | Epkinly |
| Puma Biotechnology, INC. | $79.81 | 2023-2024 | Nerlynx |
| Adc Therapeutics America, INC. | $78.39 | 2023-2025 | |
| Sobi, INC | $76.37 | 2024-2025 | |
| Stemline Therapeutics INC. | $73.09 | 2023-2024 | Orserdu |
| Coherus Oncology, INC. | $70.84 | 2023-2025 | Loqtorzi |
| Beone Medicines USA, INC. | $68.82 | 2025 | Brukinsa |
| Dendreon Pharmaceuticals LLC | $68.32 | 2023-2024 | Provenge |
| Rigel Pharmaceuticals, INC. | $67.73 | 2022-2024 | Tavalisse, Rezlidhia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.18 | 2023-2025 | Gilotrif |
| Jazz Pharmaceuticals INC. | $67.01 | 2023-2025 | |
| Acrotech Biopharma INC. | $66.54 | 2022-2025 | Beleodaq |
| Spectrum Pharmaceuticals INC. | $66.53 | 2023-2024 | Rolvedon |
| Pharmacosmos Therapeutics INC. | $60.22 | 2023-2025 | Monoferric, Cosela |
| Sumitomo Pharma America, INC. | $58.59 | 2023-2025 | Orgovyx |
| G1 Therapeutics, INC. | $56.75 | 2023 | Cosela |
| Servier Pharmaceuticals LLC | $52.47 | 2023-2025 | |
| Karyopharm Therapeutics INC. | $51.42 | 2023-2024 | Xpovio |
| Myovant Sciences INC. | $51.40 | 2022 | |
| Adaptive Biotechnologies Corporation | $45.00 | 2024-2025 | Clonoseq |
| Mirati Therapeutics, INC. | $44.57 | 2023-2024 | Krazati |
| Taiho Oncology, INC. | $44.10 | 2022-2024 | |
| Agios Pharmaceuticals, INC. | $42.34 | 2024-2025 | Pyrukynd |
| Emd Serono, INC. | $38.69 | 2023-2024 | Bavencio |
| Boston Scientific Corporation | $38.30 | 2022 | |
| Kyowa Kirin, INC. | $37.99 | 2025 | |
| Morphosys, US INC. | $35.23 | 2022-2023 | Monjuvi |
| Hema Biologics, LLC | $33.60 | 2023 | Sevenfact |
| Alexion Pharmaceuticals, INC. | $33.40 | 2023-2024 | Ultomiris, Soliris |
| Astellas Pharma US INC | $29.51 | 2024 | Padcev |
| Immunogen, INC. | $25.14 | 2023 | Elahere |
| Geron Corporation | $24.68 | 2025 | Rytelo |
| Tersera Therapeutics LLC | $23.38 | 2023 | Quzyttir |
| Kite Pharma, INC. | $22.92 | 2025 | Yescarta |
| Gilead Sciences, INC. | $22.59 | 2025 | Trodelvy |
| Amneal Pharmaceuticals LLC | $18.69 | 2025 | Alymsys |
| Syndax Pharmaceuticals, INC. | $17.69 | 2025 | |
| Blueprint Medicines Corporation | $16.69 | 2023 | Ayvakit |
| Glaxosmithkline, LLC. | $16.57 | 2025 | Ojjaara |
| Azurity Pharmaceuticals, INC. | $15.43 | 2025 | Danziten |
| Progenics Pharmaceuticals, INC. | $14.24 | 2024 | |
| Iovance Biotherapeutics, INC. | $11.52 | 2025 | Amtagvi |
Drugs and devices associated with these payments
Monjuvi $386Keytruda $295Libtayo $294Jakafi $268Verzenio $243Jaypirca $243Enhertu $217Pemfexy $208Reblozyl $201Lynparza $201Kisqali $195Erleada $189Tecentriq $184Darzalex $164Brukinsa $158Scemblix $153Onivyde $148Tecvayli $131Sarclisa $129Epkinly $129Braftovi $126Pemazyre $122Padcev $109Opdivo $106Talvey $104Balversa $104Polivy $103Besremi $103Fruzaqla $102Retevmo $101Tukysa $100Bracanalysis $99.89Calquence $95.98Mektovi $95.41Elahere $94.27Qinlock $92.79Lenvima $89.15Ninlaro $81.82Akeega $81.58Stivarga $77.27Vitrakvi $77.27Doptelet $76.37Somatuline Depot $76.25Cosela $75.73Adcetris $75.42Imbruvica $75.33Orserdu $73.09Cabometyx $71.81Lorbrena $70.55Provenge $68.32Lunsumio $67.80Columvi $67.80Nubeqa $67.40Zepzelca $67.01Rolvedon $66.53Fotivda $65.10Phesgo $64.86Venclexta $61.70Orgovyx $58.59Piqray $58.34Loqtorzi $54.42Xpovio $51.42Beleodaq $49.40Xofigo $48.18Rezlidhia $47.26Tavalisse $47.26Xtandi $47.10Clonoseq $45.00Krazati $44.57Romvimza $43.93Pyrukynd $42.34Bracanalysis Cdx $41.26Monoferric $41.24Hyqvia $39.89Xalkori $39.63Poteligeo $37.99Pluvicto $37.46Tibsovo $34.96Sevenfact $33.60Elrexfio $33.35Imfinzi $33.03Inqovi $30.59Lonsurf $30.59Datroway $30.44Gilotrif $25.85Tasigna $25.63Wayrilz $25.32Tivdak $25.09Rybrevant $24.99Rytelo $24.68Quzyttir $23.38Yescarta $22.92Trodelvy $22.59Zynyz $22.03Opdualag $22.00Injectafer $21.96Ibrance $21.60Fabhalta $21.29Zynlonta $21.23Lutathera $20.57
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Bertsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.